Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Hirasawa, Naoki ^a   Itoh, Yoshiyuki ^a   Naganawa, Shinji ^a   Ishihara, Shunichi ^a   Suzuki, Kazunori ^b   Koyama, Kazuyuki ^c   Murao, Takayuki ^d   Asano, Akiko ^e   Nomoto, Yoshihito ^f   Horikawa, Yoshimi ^g   Sasaoka, Masahiro ^h   Obata, Yasunori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Tajimi Prefectural Hospital   (Japan)

^d Ichinomiya Municipal Hospital   (Japan)

^e TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^f MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Kainan Hospital   (Japan)

^h Ise Municipal General Hospital   (Japan)

Author keywords

Chemoradiotherapy; Glottic cancer; Multiple institutes; Outcomes; Radiotherapy

Indexed keywords

CARBOPLATIN; DOCETAXEL; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LARYNX CANCER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TAXOIDS; TEGAFUR; TIME FACTORS; URACIL;

EID: 84864411403     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-122     Document Type: Article

References (33)

1. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998, 16:1318-1324.
2. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91:2081-2086. 10.1093/jnci/91.24.2081, 10601378.
3. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, Eliachar I, Strome M, Larto MA. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000, 88:876-883. 10.1002/(SICI)1097-0142(20000215)88:4<876::AID-CNCR19>3.0.CO;2-Y, 10679658.
4. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000, 355:949-955.
5. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349:2091-2098. 10.1056/NEJMoa031317, 14645636.
6. Garden AS, Morrison WH, Ang KK. Larynx and hypopharynx cancer. Clinical Radiation Oncology 2007, 727-753. Churchill Livingstone, Elsevier, Philadelphia, Gunderson LL, Tepper JE, 2.
7. Mendenhall WM, Hinerman RW, Amdur RJ, Mancuso AA, Villaret DB, Werning JW. Larynx. Perez and Brady's Principles and Practice of Radiation Oncology 2008, 975-995. Lippincott William & Wilkins, Philadelphia, Halperin EC, Perez CA, Brady LW, 5.
8. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001, 19:4029-4036.
9. Jin J, Liao Z, Gao L, Huang X, Xu G. Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences. Int J Radiat Oncol Biol Phys 2002, 54:471-478. 10.1016/S0360-3016(02)02920-6, 12243824.
10. Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys 2000, 48:723-735. 10.1016/S0360-3016(00)00635-0, 11020569.
11. Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S. Long term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Laryngoscope 2008, 118:1417-14211. 10.1097/MLG.0b013e3181781791, 18528306.
12. Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 2005, 63:1378-1386. 10.1016/j.ijrobp.2005.05.018, 16095847.
13. Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys 2005, 63:1387-1394. 10.1016/j.ijrobp.2005.05.013, 16115737.
14. Reddy SP, Hong RL, Nagda S, Emami B. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 2007, 69:1389-1394. 10.1016/j.ijrobp.2007.05.077, 17869013.
15. Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA, Reddy SP. P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 2000, 46:21-26. 10.1016/S0360-3016(99)00348-X, 10656367.
16. National Comprehensive Cancer Network clinical practice guidelines in oncology, Head and Neck Cancers v.2.2010. http://wwwnccnorg/professionals/physician_gls/f_guidelinesasp.
17. Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006, 24:3693-3704. 10.1200/JCO.2006.07.4559, 16832122.
18. Hirasawa N, Itoh Y, Naganawa S, Ishihara S, Suzuki K, Nomoto Y, Murao T, Horikawa Y, Koyama K, Sasaoka M, et al. The results of 29 respondent otolaryngologists to questionnaires for strategy of early glottic cancer. Jpn J Clin Radiol 2010, 55:541-546.
19. Itoh Y, Hirasawa N, Naganawa S, Ishihara S, Suzuki K, Koyama K, Murao T, Asano A, Nomoto Y, Horikawa Y, et al. Combined chemoradiotherapy for early glottic cancer in clinical practice in Japan: analysis of 10 institutions. Anticancer Res 2010, 30:5181-5184.
20. Furusaka T, Matuda H, Saito T, Katsura Y, Ikeda M. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottis larynx treated with radiation alone. Acta Otolaryngol 2012, 132:546-551. 10.3109/00016489.2011.646008, 22264025.
21. Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N, Nakano T. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys 2006, 64:995-1001. 10.1016/j.ijrobp.2005.10.003, 16406396.
22. Itoh Y, Fuwa N. Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer. Radiat Med 2006, 24:277-281. 10.1007/s11604-005-1517-1, 16958401.
23. Kumamoto Y, Masuda M, Kuratomi Y, Toh S, Shinokuma A, Chujo K, Yamamoto T, Komiyama S. "FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma. Head Neck 2002, 24:637-642. 10.1002/hed.10114, 12112536.
24. Tsuji H, Kiba T, Nagata M, Inoue T, Yukawa H, Yamashita T, Shimode Y, Murata H, Nagata K, Tomoda K. A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma. Oncology 2006, 71:369-373. 10.1159/000108385, 17851262.
25. Niibe Y, Nakayama M, Matsubayashi T, Takahashi H, Kitano M, Okamoto M, Hayakawa K. Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan. Anticancer Res 2007, 27:3497-3500.
26. Hirasawa N, Itoh Y, Ishihara S, Kubota S, Itoh J, Fujimoto Y, Nakashima T, Naganawa S. Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis. Head Neck Oncol 2010, 2:20. 10.1186/1758-3284-2-20, 2919535, 20673360.
27. Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 2006, 64:77-82. 10.1016/j.ijrobp.2005.06.014, 16169681.
28. Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottis caricinoma. Ann Otol Rhinol Laryngol 2006, 115:727-732.
29. Haugen H, Johansson KA, Mercke C. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. Int J Radiat Oncol Biol Phys 2002, 52:109-119. 10.1016/S0360-3016(01)01812-0, 11777628.
30. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?. Int J Radiat Oncol Biol Phys 2003, 55:322-328. 10.1016/S0360-3016(02)03938-X, 12527044.
31. Trotti A, Pajak T, Emami B, Hammond E, Jones C, Morrison W, Sagar S, Ridge J, Fu KK, Ang K. A Randomized Trial of Hyperfractionation Versus Standard Fractionation In T2 Squamous Cell Carcinoma of The Vocal Cord. Int J Radiat Oncol Biol Phys 2006, 66(1):S15.
32. Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78:461-466. 10.1016/j.ijrobp.2009.08.066, 20153124.
33. Jones DA, Mendenhall CM, Kirwan J, Morris CG, Donnan A, Holwerda S, Kraus ST, Mann CJ, Grant JR, Donnan B, Mendenhall WM. Radiation therapy for management of T1-T2 glottic cancer at a private practice. Am J Clin Oncol 2010, 33:587-590. 10.1097/COC.0b013e3181beaab0, 20051812.